The Celiac Disease Foundation congratulates David Baker, Demis Hassabis, and John Jumper on winning the 2024 Nobel Prize in Chemistry. Baker and his colleagues have transformed protein design, structure, and…
Continue ReadingA new study from researchers at Cincinnati Children’s Hospital may have found a method to predict celiac disease in patients with type 1 diabetes (T1DM). Celiac disease prevalence in children…
Continue ReadingWhat if there was a way to help your immune system become more tolerant of gluten? That’s the potential of VTP-1000, an investigational immunotherapy being studied in the AVALON celiac disease clinical trial.
Continue ReadingResearchers from the University of California Davis may have found a way to make wheat safer for those with celiac disease and improve the overall quality of gluten-free bread. Wheat…
Continue ReadingDoctoral student Adriana Carrieri from the behavioral nutrition program at Teacher’s College Columbia University is the latest recipient of the Celiac Disease Foundation’s Rising Villus Student Research Award for her…
Continue ReadingA team of interdisciplinary researchers at McMaster University in Canada, along with teams from the US, Australia, and Argentina, have made a breakthrough in understanding how the reaction to gluten…
Continue ReadingThe Celiac Disease Foundation, the nation’s leading patient advocacy organization for celiac disease, announces Leslie Saba, MB BCh BAO, as the recipient of the Celiac Disease Foundation-Jocelyn Silvester Rising Villus…
Continue ReadingNew research from Tampere University in Finland shows exciting progress in a new drug for celiac disease. This drug, ZED1227 could be used alongside a gluten-free diet to help manage…
Continue ReadingThe Celiac Disease Foundation is committed to accelerating research aimed at finding potential treatments and cures for celiac disease beyond the gluten-free diet. In order to do this, we need…
Continue ReadingA new international study published in the journal Gastroenterology sheds light on the extensive economic burden of celiac disease. In addition to the cost of gluten-free foods, the authors address…
Continue ReadingLast month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...